Core Insights - The strategic dialogue between Bausch + Lomb, China National Pharmaceutical Group, and Huaxia Eye Hospital aims to enhance collaboration in the field of eye disease surgery, focusing on technological innovation and service quality improvement [1][5][13] Group 1: Strategic Collaboration - The meeting was attended by key leaders from Bausch + Lomb and China National Pharmaceutical Group, emphasizing the importance of patient-centered care in eye health services [5][15] - Both parties aim to explore new models for eye disease diagnosis and treatment, striving for higher quality, precision, and accessibility in eye care services [1][5][15] Group 2: Historical Context and Future Directions - Bausch + Lomb has a long-standing partnership with Huaxia Eye Hospital, highlighting mutual trust and collaboration over 22 years [7] - The focus for 2026 includes enhancing academic cooperation, addressing key technical challenges, and empowering hospitals and grassroots doctors through improved product and technical support [12][15] Group 3: Achievements and Goals - In the past year, significant progress has been made in areas such as high-end surgical equipment introduction, academic platform development, and clinical training [12] - Future initiatives will include joint academic conferences and training programs to elevate the surgical skills and clinical experience of doctors, as well as exploring models to empower grassroots healthcare [12][15]